Antithymocyte globulin as the primary treatment for renal allograft rejection.
D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006084:Graft Rejection / Q000187:drug effects*; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D016030:Kidney Transplantation; D013997:Time Factors
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents